Search

everythinglearnresearchcommunity

for

Search:↓

HTLV-1-associated lichenoid dermatitis (HALD) is linked to an immune response against HTLV-1-infected cells.

2,5-DBH shows promise for improving drugs in cancer, brain disorders, and infections.

Diphenylcyclopropenone is more effective and has fewer side effects than dinitrochlorobenzene for treating alopecia areata.

Methimazole for hyperthyroidism has known and new side effects needing more study for safety.

Benzo[c]quinolizin-3-ones are effective nonsteroidal inhibitors of human steroid 5α-reductase 1.

A brominated phenoxy compound effectively inhibits a human enzyme and shows potential for clinical use.

The hamster polyomavirus middle T antigen is linked to tumors in hamsters and associates with a specific tyrosine kinase.

Personalized thiopurine dosing based on NUDT15 genotyping can improve long-term outcomes for ulcerative colitis and Crohn's disease patients.

Oral zinc sulphate is an effective and safe treatment for thallium poisoning.

Teriflunomide helps reduce multiple sclerosis symptoms and is safe for most patients.

An 8-year-old girl with vitiligo developed extra hair growth on her knee after using tacrolimus ointment.

Oral zinc sulphate is an effective and safe treatment for thallium poisoning, especially for skin and hair symptoms.

MK-5108 is safe and shows potential against tumors, especially alone.

The combination of mitoxantrone, etoposide, and prednisolone is effective for treating relapsed lymphoma with manageable side effects.

4-O-Methylhonokiol helps protect skin cells from growth-stopping effects of a protein by regulating growth-related pathways.

New pyrazole derivatives may help treat hair loss, but more testing is needed.

DFMO may help control hair growth and treat cancer.

Compound N4 effectively kills breast cancer cells and compounds N2 and N3 have strong antibacterial and antifungal properties.

Activating PPAR-γ signalling can protect hair follicle stem cells from damage caused by chemotherapy.

Chemotherapy and radiation therapy cause skin and hair damage by altering gene expression and signaling pathways.

LY320236 is a strong blocker of two enzymes that change testosterone into dihydrotestosterone and might help treat conditions related to male hormones.

Compounds 4, 4b, and 4c effectively inhibit an enzyme linked to testosterone conversion without significant toxicity.

Antibody drug conjugates show promise in targeting cancer cells while reducing harm to healthy cells.

Melatonin may protect hair follicle stem cells from damage caused by chemotherapy.

Phenobarbital-loaded chitosan nanoparticles are promising for preventing hair loss from chemotherapy.

Some drugs can cause hair loss and skin issues.

Dabrafenib was effective and well tolerated in treating thyroid cancer with a specific mutation.

Cytarabine can cause multiple organ toxicities, especially neurotoxicity, but better research methods are needed to fully understand and predict these effects.

Targeting the Smoothened receptor shows promise for treating certain cancers.